HUMANA INC's ticker is HUM and the CUSIP is 444859102. A total of 956 filers reported holding HUMANA INC in Q2 2024. The put-call ratio across all filers is 0.76 and the average weighting 0.3%.
About HUMANA INC
Humana Inc. is a leading healthcare company that offers a wide range of health insurance products and services to its customers. The company has been in operation for over 60 years and has a strong reputation for providing high-quality healthcare solutions to its customers.
Humana's mission is to help people achieve lifelong well-being by providing personalized, simplified, and connected healthcare experiences. The company offers a variety of health insurance plans, including Medicare Advantage, Medicaid, and commercial health insurance plans.
One of the key strengths of Humana is its focus on innovation and technology. The company has invested heavily in developing digital health solutions that help its customers manage their health more effectively. For example, Humana offers a mobile app that allows customers to access their health information, track their fitness goals, and connect with healthcare providers.
Humana has also been recognized for its commitment to corporate social responsibility. The company has a strong track record of supporting local communities and promoting environmental sustainability. In 2020, Humana was named one of the world's most ethical companies by the Ethisphere Institute for the 12th consecutive year.
Overall, Humana is a well-respected healthcare company that is committed to providing high-quality healthcare solutions to its customers. With its focus on innovation, technology, and corporate social responsibility, Humana is well-positioned to continue to grow and succeed in the years ahead.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $646,788 | +4.4% | 1,731 | -3.1% | 0.21% | -7.2% |
| Q1 2024 | $619,242 | -25.5% | 1,786 | -1.6% | 0.22% | -32.9% |
| Q4 2023 | $830,925 | -24.5% | 1,815 | -19.8% | 0.33% | +2.8% |
| Q3 2023 | $1,100,995 | -2.1% | 2,263 | -10.0% | 0.32% | +1.6% |
| Q2 2023 | $1,124,085 | -4.0% | 2,514 | +4.2% | 0.32% | -3.6% |
| Q1 2023 | $1,171,415 | +92943.3% | 2,413 | -1.9% | 0.33% | -7.3% |
| Q4 2022 | $1,259 | – | 2,459 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACR Alpine Capital Research, LLC | 383,629 | $68,294,000 | 8.30% |
| Raveneur Investment Group LP | 116,000 | $20,650,000 | 7.23% |
| March Altus Capital Management LP | 6,403 | $1,140,000 | 7.17% |
| Conatus Capital Management LP | 622,491 | $110,816,000 | 7.01% |
| Glenview Capital Management | 5,016,536 | $893,044,000 | 4.08% |
| Summit Street Capital Management, LLC | 24,015 | $4,275,000 | 3.82% |
| BRIDGER MANAGEMENT, LLC | 301,224 | $53,624,000 | 3.58% |
| CONTRAVISORY INVESTMENT MANAGEMENT, INC. | 100,203 | $17,838,000 | 3.58% |
| B & T Capital Management DBA Alpha Capital Management | 33,710 | $4,842,000 | 3.40% |
| Sivik Global Healthcare LLC | 55,000 | $9,791,000 | 3.33% |